APLT - Applied Therapeutics Inc
IEX Last Trade
6.35
0.270 4.252%
Share volume: 1,097,291
Last Updated: Fri 30 Aug 2024 09:59:59 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$6.08
0.27
4.44%
Summary score
24%
Profitability
25%
Dept financing
4%
Liquidity
50%
Performance
23%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-37.05%
Return on assets
-26.9%
Return on sales
0%
Return on invested capital
157.28%
Total debt ratio
20.28%
Debt ratio change over timeo
-0.89%
Current Ratio
7.62%
Quick Ratio
0%
Cash Position Ratio
5.13%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-29.6%
Return on assets
-22.91%
Return on sales
0%
Return on invested capital
170.33%
Total debt ratio
17.42%
Debt ratio change over timeo
-0.89%
Current Ratio
9.04%
Quick Ratio
0%
Cash Position Ratio
4.9%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-21.55%
Return on assets
-18.78%
Return on sales
0%
Return on invested capital
166.74%
Total debt ratio
13.53%
Debt ratio change over time
-0.93%
Current Ratio
7.87%
Quick Ratio
0%
Cash Position Ratio
5.34%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-118.28%
Return on assets
-114.47%
Return on sales
0%
Return on invested capital
6.24%
Total debt ratio
-89.06%
Debt ratio change over time
-0.89%
Current Ratio
4.71%
Quick Ratio
0%
Cash Position Ratio
2.37%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | APLT | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -37.05% | -3.05% | 11.55% | 6.27% |
| Return on assets | -26.9% | 3.6% | 3.57% | 5.27% |
| Return on sales | 0% | 32.14% | 42.16% | 33.08% |
| Return on invested capital | 157.28% | 5.09% | 7.99% | 13.19% |
| Profitability | 25% | 37% | 68% | 60% |
| Total debt ratio | 20.28% | 101.18% | 74.11% | 29.58% |
| Debt ratio change over time | -0.89% | 6.09% | 6.03% | 1.53% |
| Dept financing | 5% | 50% | 43% | 14% |
| Current Ratio | 9.04% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 4.9% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 19% | 40% | 41% |
| Short-term ratios | APLT | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -29.6% | -25.62% | 17.94% | 7.14% |
| Return on assets | -22.91% | 3.26% | 3.67% | 4.71% |
| Return on sales | 0% | 31.22% | 37.5% | 33.58% |
| Return on invested capital | 170.33% | 8.14% | 7.17% | 18.16% |
| Profitability | 25% | 39% | 71% | 60% |
| Total debt ratio | 17.42% | 105.33% | 83.42% | 27.49% |
| Debt ratio change over time | -0.89% | -23.44% | 9.66% | 0.6% |
| Dept financing | 4% | 25% | 45% | 8% |
| Current Ratio | 9.04% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 4.9% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 30% | 24% | 42% |